Global Pharma Management

Thursday
Sep 09th
  • Login
  • Sign up
    Registration
    Fields marked with an asterisk (*) are required.
    Name: *
    Username: *
    E-mail: *
    Password: *
    Verify Password: *
  • Search
Text size
  • Increase font size
  • Default font size
  • Decrease font size
Home arrow Knowledge Bank arrow News arrow Ricerca Biosciences to acquire Discovery and Preclinical business of MDS Pharma Services
Ricerca Biosciences to acquire Discovery and Preclinical business of MDS Pharma Services PDF Print E-mail
Wednesday, 10 March 2010
 
Ricerca Biosciences, LLC, announced the finalization of the acquisition of the Discovery and Preclinical business of MDS Pharma Services with facilities and almost 600 associates in Bothell, Washington; Lyon, France; and Taipei, Taiwan.

“With facilities worldwide combining local experience, immense scientific expertise and a strong commitment to excellent client service, we provide unique discovery and development services. Our expanded organization is a research partner clients can rely on to think strategically about projects, anticipate needs and rapidly deliver study results.”

The expanded organization provides the biopharmaceutical industry with access to a global contract research organization (CRO) focused on the developmental phase between intellectual property (IP) and submission of the investigational new drug (IND) application. The increased capacity and capabilities deliver numerous benefits, including:

  • Global toxicology allowing coordination of projects between North America, Europe and Asia
  • Access to cGMP and non-GMP API synthesis and process development for IND-enabling toxicology performed in North America and Europe
  • Expanded and enhanced DMPK services and efficacy models
  • Streamlined lead optimization service combining efficacy and biomarker assays with medicinal chemistry
  • Complete pharmacological profiling services including molecular, cellular, tissue and in vivo assays of development candidates
  • Radio labeled compound synthesis available for all locations worldwide

Ricerca Chairman and CEO Ian Lennox stated, “With facilities worldwide combining local experience, immense scientific expertise and a strong commitment to excellent client service, we provide unique discovery and development services. Our expanded organization is a research partner clients can rely on to think strategically about projects, anticipate needs and rapidly deliver study results.”

 
< Prev   Next >
[ Back ]

Publication

Global Pharma Management is a leading international magazine, published in India. The magazine is published two times in a year with a circulation figure of 75,015 (print + online, publisher's survey).

Advertising Products

B. Braun is one of the world's leading companies in international health-care.
The principal activities within customer projects are product variation and combination, pharmaceutical contract manufacturing and common development.
Advertisement
Hospital Management Asia
Asia Hospital & Healthcare Circulation
Global Pharma Management
Global Pharmaceutical Circulation.
Hospital & Healthcare Management
Global Hospital & Healthcare circulation
To Join With US
Contact Avni Media Pvt.Ltd.,